Income Statement Enimmune corporation

Stocks

6564

TW0006564008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 2026-09-21			5-day change	1st Jan Change
16.55 ^TWD	0.00%		+7.82%	-19.66%

08-12	Enimmune Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-08	Enimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI

5739208722fe48a719cc0cc.Fq0Plcj1VY-L-cuJhfNi6NzWxXoSX9xg7S5UhJol-Ag.Q-l48pixZby7iv3mt5Yh0Lq1rh1IcrEv1W0Fte5TtEVF9WKnkZAx68Cggg

Published financial data: ENIMMUNE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Revenues	110M	188M	43.49M	39.92M	48.19M
Total Revenues	110M	188M	43.49M	39.92M	48.19M
Cost of Goods Sold, Total	71.1M	168M	66.87M	25.69M	40.18M
Gross Profit	38.72M	20.84M	-23.37M	14.23M	8.02M
Selling General & Admin Expenses, Total	42.64M	54.96M	80.66M	80.56M	77.71M
Provision for Bad Debts	-	4.92M	168K	-146K	-1.58M
R&D Expenses	54.76M	247M	139M	84.95M	117M
Other Operating Expenses, Total	97.39M	307M	220M	165M	193M
Operating Income	-58.67M	-286M	-243M	-151M	-185M
Interest Expense, Total	-225K	-315K	-977K	-2.2M	-4.01M
Interest And Investment Income	2.39M	1.29M	1.94M	2.58M	3.58M
Net Interest Expenses	2.17M	974K	960K	375K	-433K
Currency Exchange Gains (Loss)	-	7.45M	-337K	-601K	98K
Other Non Operating Income (Expenses)	9.26M	10.9M	5.16M	-14.21M	21.04M
EBT, Excl. Unusual Items	-47.25M	-267M	-238M	-166M	-165M
EBT, Incl. Unusual Items	-47.25M	-267M	-238M	-166M	-165M
Earnings From Continuing Operations	-47.25M	-267M	-238M	-166M	-165M
Net Income to Company	-47.25M	-267M	-238M	-166M	-165M
Minority Interest	-	19.12M	13.95M	8.03M	192K
Net Income - (IS)	-47.25M	-248M	-224M	-158M	-164M
Net Income to Common Incl Extra Items	-47.25M	-248M	-224M	-158M	-164M
Net Income to Common Excl. Extra Items	-47.25M	-248M	-224M	-158M	-164M
Per Share Items
Net EPS - Basic	-0.79	-3.88	-3.4	-2.2	-2.28
Basic EPS - Continuing Operations	-0.79	-3.88	-3.4	-2.2	-2.28
Basic Weighted Average Shares Outstanding	60M	63.87M	65.8M	71.52M	72.13M
Net EPS - Diluted	-0.79	-3.88	-3.4	-2.2	-2.28
Diluted EPS - Continuing Operations	-0.79	-3.88	-3.4	-2.2	-2.28
Diluted Weighted Average Shares Outstanding	60M	63.87M	65.8M	71.52M	72.13M
Normalized Basic EPS	-0.49	-2.31	-2.05	-1.33	-1.42
Normalized Diluted EPS	-0.49	-2.31	-2.05	-1.33	-1.42
Supplemental Items
EBITDA	-50.18M	-278M	-238M	-146M	-179M
EBITA	-53.72M	-281M	-239M	-146M	-180M
EBIT	-58.67M	-286M	-243M	-151M	-185M
EBITDAR	-49.42M	-277M	-237M	-145M	-179M
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-9.45M	-48.54M	-44.52M	-31.33M	-32.26M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	9.82M	48.54M	44.52M	31.33M	32.26M
Normalized Net Income	-29.53M	-148M	-135M	-95.46M	-103M
Supplemental Operating Expense Items
Selling and Marketing Expenses	6.11M	7.05M	28.7M	34.15M	37.11M
General and Administrative Expenses	35.76M	46.83M	51.2M	45.63M	40.2M
Research And Development Expense From Footnotes	54.76M	247M	139M	84.95M	117M
Net Rental Expense, Total	767K	1.09M	768K	785K	402K
Imputed Operating Lease Interest Expense	137K	145K	159K	180K	92.52K
Imputed Operating Lease Depreciation	630K	941K	609K	605K	309K
Stock-Based Comp., Other (Total)	-	2.27M	3.68M	3.03M	1.75M
Total Stock-Based Compensation	-	2.27M	3.68M	3.03M	1.75M

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Assets
Cash And Equivalents	118M	394M	360M	485M	202M
Short Term Investments	231M	92.9M	4.9M	4.9M	23.4M
Total Cash And Short Term Investments	350M	487M	365M	490M	226M
Accounts Receivable, Total	21.99M	5.22M	11.92M	12.5M	14.52M
Other Receivables	25.54M	28.55M	28.38M	29.73M	31.44M
Total Receivables	47.53M	33.77M	40.3M	42.23M	45.96M
Inventory	82.82M	88.12M	37.64M	35.64M	21.22M
Prepaid Expenses	2.05M	2.37M	4.9M	2.58M	2.63M
Other Current Assets, Total	1.37M	16.54M	17.59M	17.78M	22.57M
Total Current Assets	484M	628M	465M	588M	318M
Gross Property Plant And Equipment	7.94M	11.94M	10.11M	8.75M	20.11M
Accumulated Depreciation	-2.02M	-3.42M	-4.24M	-4.9M	-5.97M
Net Property Plant And Equipment	5.92M	8.52M	5.88M	3.86M	14.14M
Other Intangibles, Total	119M	114M	109M	104M	99.08M
Other Long-Term Assets, Total	1.12M	24.32M	24.47M	27.63M	24.71M
Total Assets	610M	775M	605M	724M	456M
Liabilities
Accounts Payable, Total	10.36M	4M	18.06M	2.95M	2.85M
Accrued Expenses, Total	-	-	-	19.4M	29.87M
Short-term Borrowings	-	20M	40M	100M	125M
Current Portion of Long-Term Debt	2.09M	2.11M	2.13M	2.24M	10M
Current Portion of Leases	775K	1.82M	1.84M	775K	3.48M
Unearned Revenue Current, Total	1.72M	1.72M	-	-	-
Other Current Liabilities	19.88M	74.3M	110M	114M	102M
Total Current Liabilities	34.82M	104M	172M	240M	274M
Long-Term Debt	5.22M	3.11M	984K	4.78M	28.22M
Long-Term Leases	-	2.62M	775K	-	4.49M
Total Liabilities	40.04M	110M	173M	244M	306M
Common Stock, Total	600M	658M	658M	721M	721M
Additional Paid In Capital	17.27M	168M	11.56M	161M	25.67M
Retained Earnings	-47.25M	-281M	-345M	-510M	-589M
Comprehensive Income and Other	-	-152K	-2.68M	1.91M	-8.51M
Total Common Equity	570M	545M	322M	374M	150M
Minority Interest	-	121M	109M	105M	-
Total Equity	570M	665M	431M	479M	150M
Total Liabilities And Equity	610M	775M	605M	724M	456M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	60M	65.8M	65.8M	72.13M	72.13M
ECS Total Common Shares Outstanding	60M	65.8M	65.8M	72.13M	72.13M
Book Value / Share	9.5	8.28	4.89	5.19	2.08
Tangible Book Value	451M	430M	213M	270M	50.61M
Tangible Book Value Per Share	7.51	6.54	3.23	3.74	0.7
Total Debt	8.08M	29.66M	45.73M	108M	171M
Net Debt	-342M	-457M	-319M	-382M	-54.59M
Debt Equivalent Oper. Leases	6.14M	8.69M	6.14M	6.28M	3.22M
Minority Interest, Total (Incl. Fin. Div)	-	121M	109M	105M	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	17.81M	13.41M	5.84M	1.17M	852K
Inventories - Work In Process, Total	-	5.46M	-	59K	58K
Inventories - Finished Goods, Total	40.62M	42.22M	44.75M	23.82M	21.85M
Machinery, Total	4.65M	4.92M	4.92M	5.39M	6.5M
Full Time Employees	38	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	67K	-	168K	22K	11K

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Net Income	-47.25M	-248M	-224M	-158M	-164M
Depreciation & Amortization - CF	3.53M	3.24M	2.64M	2.49M	3.98M
Amortization of Goodwill and Intangible Assets - (CF)	4.95M	4.95M	4.95M	4.95M	4.95M
Depreciation & Amortization, Total	8.49M	8.2M	7.6M	7.44M	8.94M
Amortization of Deferred Charges, Total - (CF)	137K	152K	152K	152K	136K
Stock-Based Compensation (CF)	-	2.27M	3.68M	3.03M	1.75M
Provision and Write-off of Bad Debts	67K	4.92M	168K	-146K	-1.58M
Other Operating Activities, Total	17K	-19.33M	-13.89M	9.31M	-17.35M
Change In Accounts Receivable	1.19M	17.46M	-7.47M	-447K	-15K
Change In Inventories	-9.79M	-8.48M	44.78M	-6.64M	1.11M
Change In Accounts Payable	-6.75M	-6.39M	14.09M	-15.17M	-360K
Change in Unearned Revenues	1.72M	-	-	-	-
Change in Other Net Operating Assets	-19.38M	48.53M	36.5M	16.24M	28.46M
Cash from Operations	-71.55M	-201M	-138M	-144M	-143M
Capital Expenditure	-2.98M	-347K	-	-473K	-4.18M
Sale (Purchase) of Intangible assets	-430K	-	-	-	-
Investment in Marketable and Equity Securities, Total	93.5M	123M	88M	-	-24.5M
Other Investing Activities, Total	8K	-23.21M	-142K	-3.17M	2.93M
Cash from Investing	90.1M	99.94M	87.86M	-3.64M	-25.75M
Short Term Debt Issued, Total	-	20M	20M	60M	25M
Long-Term Debt Issued, Total	-	-	-	6.11M	38.56M
Total Debt Issued	-	20M	20M	66.11M	63.56M
Long-Term Debt Repaid, Total	-3.94M	-3.95M	-3.97M	-4.06M	-10.35M
Total Debt Repaid	-3.94M	-3.95M	-3.97M	-4.06M	-10.35M
Issuance of Common Stock	-	220M	-	202M	-
Other Financing Activities, Total	-	145M	-	-	-156M
Cash from Financing	-3.94M	381M	16.03M	264M	-103M
Foreign Exchange Rate Adjustments	-	-4.59M	-38K	8.34M	-10.42M
Net Change in Cash	14.61M	276M	-34.28M	125M	-283M
Supplemental Items
Cash Interest Paid	208K	277K	919K	2.12M	3.92M
Levered Free Cash Flow	-61.94M	-128M	-53.27M	-74.54M	-107M
Unlevered Free Cash Flow	-61.79M	-128M	-52.65M	-73.16M	-105M
Change In Net Working Capital	30.34M	-41.04M	-88.08M	-11.15M	-4.37M
Net Debt Issued / Repaid	-3.94M	16.05M	16.03M	62.05M	53.21M

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Profitability
Return on Assets	-5.79	-25.85	-22.06	-14.22	-19.63
Return on Total Capital	-6.07	-28.12	-25.96	-17.75	-25.5
Return On Equity %	-7.96	-43.24	-43.34	-36.37	-52.33
Return on Common Equity	-7.96	-44.49	-51.64	-45.27	-62.76
Margin Analysis
Gross Profit Margin %	35.26	11.06	-53.74	35.64	16.63
SG&A Margin	38.83	29.17	185.46	201.84	161.24
EBITDA Margin %	-45.7	-147.66	-546.53	-364.6	-371.87
EBITA Margin %	-48.91	-149.38	-548.4	-366.25	-374.09
EBIT Margin %	-53.42	-152.01	-559.79	-378.66	-384.37
Income From Continuing Operations Margin %	-43.02	-141.75	-546.49	-414.81	-341.41
Net Income Margin %	-43.02	-131.6	-514.42	-394.7	-341.01
Net Avail. For Common Margin %	-43.02	-131.6	-514.42	-394.7	-341.01
Normalized Net Income Margin	-26.89	-78.45	-309.49	-239.15	-212.98
Levered Free Cash Flow Margin	-56.4	-67.88	-122.47	-186.74	-222.57
Unlevered Free Cash Flow Margin	-56.27	-67.78	-121.06	-183.29	-217.37
Asset Turnover
Asset Turnover	0.17	0.27	0.06	0.06	0.08
Fixed Assets Turnover	15	26.1	6.04	8.2	5.36
Receivables Turnover (Average Receivables)	4.85	13.85	5.08	3.27	3.57
Inventory Turnover (Average Inventory)	1.14	1.96	1.06	0.7	1.41
Short Term Liquidity
Current Ratio	13.89	6.04	2.71	2.45	1.16
Quick Ratio	11.41	5.01	2.36	2.22	0.99
Operating Cash Flow to Current Liabilities	-2.05	-1.93	-0.8	-0.6	-0.52
Days Sales Outstanding (Average Receivables)	75.19	26.35	71.9	111.92	102.31
Days Outstanding Inventory (Average Inventory)	320.92	186.16	343.22	522.02	258.3
Average Days Payable Outstanding	44.88	15.16	245.64	162.31	41.1
Cash Conversion Cycle (Average Days)	351.23	197.35	169.48	471.64	319.51
Long Term Solvency
Total Debt/Equity	1.42	4.46	10.6	22.5	114.36
Total Debt / Total Capital	1.4	4.27	9.59	18.36	53.35
LT Debt/Equity	0.92	0.86	0.41	1	21.85
Long-Term Debt / Total Capital	0.9	0.82	0.37	0.81	10.19
Total Liabilities / Total Assets	6.56	14.15	28.68	33.78	67.18
EBIT / Interest Expense	-260.76	-909.26	-249.21	-68.64	-46.16
EBITDA / Interest Expense	-223.04	-883.24	-241.43	-65.26	-43.93
(EBITDA - Capex) / Interest Expense	-236.28	-884.34	-241.43	-65.47	-44.97
Total Debt / EBITDA	-0.16	-0.11	-0.19	-0.75	-0.97
Net Debt / EBITDA	6.81	1.64	1.35	2.66	0.31
Total Debt / (EBITDA - Capex)	-0.15	-0.11	-0.19	-0.75	-0.95
Net Debt / (EBITDA - Capex)	6.43	1.64	1.35	2.65	0.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	380.08	71.56	-76.92	-8.23	20.74
Gross Profit, 1 Yr. Growth %	371.14	-46.18	-212.14	-160.87	-43.65
EBITDA, 1 Yr. Growth %	-33.77	454.39	-15.12	-38.78	23.15
EBITA, 1 Yr. Growth %	-30.93	423.96	-15.26	-38.71	23.33
EBIT, 1 Yr. Growth %	-29.07	388.17	-14.99	-37.92	22.56
Earnings From Cont. Operations, 1 Yr. Growth %	-36.54	465.31	-11.01	-30.34	-0.63
Net Income, 1 Yr. Growth %	-36.54	424.83	-9.77	-29.59	4.32
Normalized Net Income, 1 Yr. Growth %	-36.54	400.55	-8.93	-29.09	7.53
Diluted EPS Before Extra, 1 Yr. Growth %	-43.57	391.45	-12.42	-35.22	3.51
Accounts Receivable, 1 Yr. Growth %	-5.45	-76.27	128.38	4.85	16.22
Inventory, 1 Yr. Growth %	96.2	6.4	-57.28	-5.31	-40.45
Net Property, Plant and Equip., 1 Yr. Growth %	-32.19	43.99	-31.04	-34.35	266.61
Total Assets, 1 Yr. Growth %	-7.23	27.05	-21.97	19.65	-36.98
Tangible Book Value, 1 Yr. Growth %	-8.64	-4.52	-50.56	26.9	-81.25
Common Equity, 1 Yr. Growth %	-7.65	-4.47	-40.88	16.19	-59.98
Cash From Operations, 1 Yr. Growth %	-33.39	180.41	-31.15	4.09	-0.37
Capital Expenditures, 1 Yr. Growth %	-28.93	-88.35	-	-	783.09
Levered Free Cash Flow, 1 Yr. Growth %	-32.61	106.5	-58.35	39.93	43.91
Unlevered Free Cash Flow, 1 Yr. Growth %	-32.69	106.65	-58.77	38.94	43.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	651.62	186.99	-37.07	-53.97	5.26
Gross Profit, 2 Yr. CAGR %	609.61	59.24	-22.31	-17.38	-41.44
EBITDA, 2 Yr. CAGR %	-12.78	91.62	117.64	-27.91	-13.17
EBITA, 2 Yr. CAGR %	-10.4	90.24	110.72	-27.93	-13.06
EBIT, 2 Yr. CAGR %	-9.65	86.08	103.71	-27.36	-12.77
Earnings From Cont. Operations, 2 Yr. CAGR %	-8.67	89.4	124.3	-21.26	-16.8
Net Income, 2 Yr. CAGR %	-8.67	82.5	117.62	-20.29	-14.3
Normalized Net Income, 2 Yr. CAGR %	-8.67	78.22	113.51	-19.64	-12.68
Diluted EPS Before Extra, 2 Yr. CAGR %	-21.74	66.53	107.47	-24.68	-18.11
Accounts Receivable, 2 Yr. CAGR %	727.64	-52.63	-26.38	54.74	10.39
Inventory, 2 Yr. CAGR %	2.19K	44.48	-32.58	-36.4	-24.91
Net Property, Plant and Equip., 2 Yr. CAGR %	1.02K	-1.19	-0.36	-32.72	55.14
Total Assets, 2 Yr. CAGR %	36.1	8.56	-0.43	-3.37	-13.16
Tangible Book Value, 2 Yr. CAGR %	52.06	-6.6	-31.29	-20.79	-51.22
Common Equity, 2 Yr. CAGR %	32.71	-6.08	-24.85	-17.12	-31.81
Cash From Operations, 2 Yr. CAGR %	9.27	36.67	38.95	-15.35	1.84
Capital Expenditures, 2 Yr. CAGR %	-	-71.22	-	16.75	-
Levered Free Cash Flow, 2 Yr. CAGR %	13.35	17.96	-7.26	-23.66	41.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.23	17.94	-7.69	-24.31	41.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	355.9	359.35	23.88	-28.64	-36.52
Gross Profit, 3 Yr. CAGR %	364.65	200.38	41.68	-28.38	-27.28
EBITDA, 3 Yr. CAGR %	-20.36	61.56	46.39	42.6	-13.83
EBITA, 3 Yr. CAGR %	-18.53	61.42	45.29	39.61	-13.8
EBIT, 3 Yr. CAGR %	-17.45	58.55	43.31	37.08	-13.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-22.32	67.69	47.25	51.89	-14.91
Net Income, 3 Yr. CAGR %	-22.32	63.58	44.31	49.4	-12.81
Normalized Net Income, 3 Yr. CAGR %	-22.32	61.02	42.49	47.86	-11.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-31.32	44.38	34.42	40.75	-16.26
Accounts Receivable, 3 Yr. CAGR %	-	153.32	-19.98	-17.17	40.66
Inventory, 3 Yr. CAGR %	-	723.12	-3.75	-24.5	-37.78
Net Property, Plant and Equip., 3 Yr. CAGR %	-	465.95	-12.35	-13.29	18.4
Total Assets, 3 Yr. CAGR %	16.47	33.01	-2.75	5.86	-16.2
Tangible Book Value, 3 Yr. CAGR %	22.5	30.21	-24.45	-15.7	-51
Common Equity, 3 Yr. CAGR %	14.59	18.94	-19.5	-13.1	-34.98
Cash From Operations, 3 Yr. CAGR %	-5.89	49.6	8.74	26.19	-10.62
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-45.84	129.18
Levered Free Cash Flow, 3 Yr. CAGR %	7.21	38.44	-16.63	6.37	-5.7
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.13	38.37	-16.91	5.79	-6.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	123.53	156.41	106.48	83.02	16.07
Gross Profit, 5 Yr. CAGR %	127.03	70.49	127.21	79.24	-0.5
EBITDA, 5 Yr. CAGR %	-5.23	52.14	19.06	17.14	18.79
EBITA, 5 Yr. CAGR %	-3.93	52.49	19.14	16.92	18.31
EBIT, 5 Yr. CAGR %	-3.14	50.09	18.48	16.03	17.5
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.39	50.78	18.72	23.93	17.19
Net Income, 5 Yr. CAGR %	-6.39	48.55	17.29	22.7	17.16
Normalized Net Income, 5 Yr. CAGR %	-6.39	47.15	16.4	21.94	17.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-13.63	35.28	6.88	11.3	10.25
Accounts Receivable, 5 Yr. CAGR %	155.99	46.36	-	107.99	-8.99
Inventory, 5 Yr. CAGR %	99.91	483.74	-	195.57	-12.85
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	141.45	10.14
Total Assets, 5 Yr. CAGR %	6.53	13.06	9.39	17.05	-7.06
Tangible Book Value, 5 Yr. CAGR %	5.22	9.88	-2.8	6.73	-36.58
Common Equity, 5 Yr. CAGR %	5.24	5.98	-3.2	2.94	-24.67
Cash From Operations, 5 Yr. CAGR %	0.02	33.92	9.98	19.13	5.93
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-0.06
Levered Free Cash Flow, 5 Yr. CAGR %	4.91	8.28	1.17	9.11	3.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.86	8.25	0.94	8.7	2.68